SIX Swiss Exchange · Healthcare
Invest in Addex Therapeutics stock from India
Indian and foreign residents can buy Addex Therapeutics (ADXN) shares directly through Paasa.
By Paasa · Updated
Addex Therapeutics at a glance
- Price
- CHF 0.02+CHF 0.00 (0.00%)
- Market cap
- CHF 3.13M
- Day range
- CHF 0.02 – CHF 0.02
- P/E
- -0.44
- Dividend yield
- None
- Volume
- 73.12K
- 1 month
- -28.47%
- 6 months
- -48.50%
- YTD
- -62.82%
- 1 year
- -65.89%
- 5 years
- -98.58%
Addex Therapeutics statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 173.0K | CHF 410.0K | CHF 1.6M | CHF 1.4M | CHF 2.9M |
| Gross profit | CHF 164.4K | −CHF 444.3K | −CHF 5.3M | −CHF 13.2M | −CHF 9.7M |
| Operating income | −CHF 2.8M | −CHF 2.8M | −CHF 2.2M | −CHF 20.5M | −CHF 15.5M |
| Net income | −CHF 6.7M | CHF 7.1M | −CHF 10.6M | −CHF 20.8M | −CHF 15.4M |
| Earnings per share | −CHF 0.06 | CHF 0.07 | −CHF 0.14 | −CHF 0.46 | −CHF 0.45 |
| EBITDA | −CHF 2.8M | −CHF 4.6M | −CHF 10.3M | −CHF 20.4M | −CHF 14.9M |
| Total assets | CHF 6.4M | CHF 10.7M | CHF 4.6M | CHF 8.3M | CHF 22.5M |
| Total debt | CHF 34.7K | CHF 42.0K | CHF 344.3K | CHF 373.1K | CHF 482.0K |
| Cash and short-term investments | CHF 1.6M | CHF 3.3M | CHF 3.9M | CHF 7.0M | CHF 20.5M |
| Shareholders' equity | CHF 4.8M | CHF 9.7M | CHF 1.1M | CHF 4.9M | CHF 16.9M |
| Operating cash flow | −CHF 2.2M | −CHF 5.4M | −CHF 8.0M | −CHF 16.4M | −CHF 14.7M |
| Free cash flow | −CHF 2.2M | −CHF 5.4M | −CHF 8.0M | −CHF 16.4M | −CHF 14.7M |
| Capital expenditure | CHF 0.0 | −CHF 1.3K | −CHF 6.8K | −CHF 581.0 | −CHF 31.5K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
| Basilea Pharmaceutica | BSLN.SW | CHF 68.40 | CHF 846.56M |
| Santhera Pharmaceuticals | SANN.SW | CHF 15.34 | CHF 227.51M |
| Newron Pharmaceuticals | NWRN.SW | CHF 8.34 | CHF 173.52M |
| EvoNext | EVE.SW | CHF 2.16 | CHF 15.58M |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 0 buy · 1 hold · 0 sell. Consensus: Hold.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Addex Therapeutics from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search ADXN and buy
Find Addex Therapeutics by name or by its ticker, ADXN, and place your order.
Why invest in Addex Therapeutics from India
What Addex Therapeutics does
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Addex Therapeutics operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Addex Therapeutics stock from India?
Yes. Indian residents and NRIs can buy Addex Therapeutics (ADXN) shares directly through Paasa. Addex Therapeutics is listed on the SIX Swiss Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Addex Therapeutics shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.